Beta Blockers Linked To Severe Risks For Women: Study
A groundbreaking international study has sent ripples through the cardiology community, revealing that beta blockers, long a staple post-myocardial infarction, may offer no benefit and even elevate risks for women with uncomplicated heart attacks and preserved heart function. The "REALIZE" study, published today in The Lancet, challenges decades of clinical orthodoxy, prompting an urgent re-evaluation of prescription protocols globally.















